Market Closed -
Hong Kong S.E.
04:09:00 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
0.28
HKD
|
0.00%
|
|
0.00%
|
-13.85%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
5,193
|
5,193
|
5,193
|
5,193
|
3,311
|
2,584
|
Enterprise Value (EV)
1 |
3,693
|
3,443
|
3,453
|
3,512
|
1,533
|
1,820
|
P/E ratio
|
-48.8
x
|
81.2
x
|
-618
x
|
-18.5
x
|
150
x
|
183
x
|
Yield
|
-
|
0.36%
|
-
|
-
|
0.34%
|
0.32%
|
Capitalization / Revenue
|
4.68
x
|
4.63
x
|
4.6
x
|
4.86
x
|
2.23
x
|
1.68
x
|
EV / Revenue
|
3.33
x
|
3.07
x
|
3.06
x
|
3.28
x
|
1.03
x
|
1.19
x
|
EV / EBITDA
|
39.7
x
|
53.3
x
|
42.5
x
|
408
x
|
9.15
x
|
23
x
|
EV / FCF
|
9.41
x
|
64.7
x
|
-16.6
x
|
14.4
x
|
6.76
x
|
-15.9
x
|
FCF Yield
|
10.6%
|
1.55%
|
-6.02%
|
6.95%
|
14.8%
|
-6.29%
|
Price to Book
|
1.29
x
|
1.28
x
|
1.29
x
|
1.36
x
|
0.86
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
7,526,134
|
7,526,134
|
7,526,134
|
7,526,134
|
7,526,134
|
6,800,548
|
Reference price
2 |
0.6900
|
0.6900
|
0.6900
|
0.6900
|
0.4400
|
0.3800
|
Announcement Date
|
4/29/18
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,109
|
1,122
|
1,129
|
1,069
|
1,484
|
1,536
|
EBITDA
1 |
93.01
|
64.64
|
81.24
|
8.604
|
167.5
|
79.26
|
EBIT
1 |
30.39
|
7.3
|
24.29
|
-48.71
|
114.1
|
16.49
|
Operating Margin
|
2.74%
|
0.65%
|
2.15%
|
-4.56%
|
7.69%
|
1.07%
|
Earnings before Tax (EBT)
1 |
-71.38
|
115
|
38.77
|
-232.9
|
126.5
|
82.5
|
Net income
1 |
-107.7
|
64.01
|
-8.414
|
-281
|
22.01
|
15.29
|
Net margin
|
-9.72%
|
5.71%
|
-0.75%
|
-26.29%
|
1.48%
|
1%
|
EPS
2 |
-0.0141
|
0.008500
|
-0.001117
|
-0.0373
|
0.002924
|
0.002082
|
Free Cash Flow
1 |
392.6
|
53.25
|
-208.1
|
244.1
|
226.9
|
-114.4
|
FCF margin
|
35.41%
|
4.75%
|
-18.43%
|
22.83%
|
15.29%
|
-7.45%
|
FCF Conversion (EBITDA)
|
422.13%
|
82.38%
|
-
|
2,836.78%
|
135.46%
|
-
|
FCF Conversion (Net income)
|
-
|
83.18%
|
-
|
-
|
1,030.62%
|
-
|
Dividend per Share
|
-
|
0.002500
|
-
|
-
|
0.001500
|
0.001200
|
Announcement Date
|
4/29/18
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,500
|
1,750
|
1,740
|
1,682
|
1,779
|
764
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
393
|
53.2
|
-208
|
244
|
227
|
-114
|
ROE (net income / shareholders' equity)
|
-2.18%
|
1.98%
|
0.24%
|
-6.13%
|
1.8%
|
1.23%
|
ROA (Net income/ Total Assets)
|
0.38%
|
0.1%
|
0.32%
|
-0.65%
|
1.53%
|
0.22%
|
Assets
1 |
-28,044
|
65,320
|
-2,597
|
43,025
|
1,437
|
7,036
|
Book Value Per Share
2 |
0.5400
|
0.5400
|
0.5300
|
0.5100
|
0.5100
|
0.5100
|
Cash Flow per Share
2 |
0.1800
|
0.2300
|
0.2400
|
0.1400
|
0.1200
|
0.1400
|
Capex
1 |
82
|
79.7
|
55
|
35.3
|
19.9
|
37.2
|
Capex / Sales
|
7.4%
|
7.1%
|
4.87%
|
3.3%
|
1.34%
|
2.42%
|
Announcement Date
|
4/29/18
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
|
1st Jan change
|
Capi.
|
---|
| -13.85% | 243M | | +13.70% | 81.68B | | -29.20% | 69.23B | | +9.72% | 29.08B | | -11.43% | 16.88B | | -0.43% | 16.85B | | -0.31% | 15.15B | | +3.42% | 12.62B | | +28.34% | 12.47B | | -30.70% | 11.89B |
Other Healthcare Facilities & Services
|